Ton van der Kaaij, Reach specialist at Quaker Chemical, presents the company's Reach experiences at the REACH USA 2010 conference in Chicago, US in April
Lena Perenius of Cefic discusses global chemicals regulationajagger
The document discusses challenges and opportunities in global chemical regulation. It outlines the goal of minimizing adverse impacts of chemicals by 2020 as agreed in 2002. It discusses trends towards regulatory convergence and cooperation between governments and industry. The Global Product Strategy is presented as industry's contribution to achieving the goals through initiatives like hazard information sharing and capacity building in developing countries by 2020.
Braskem announced strong fourth quarter 2009 results. EBITDA reached $614 million for the quarter, though this was lower than the previous quarter due to higher costs and lower sales volume. For the full year 2009, Braskem achieved $2.5 billion in EBITDA with a margin of 16.2%, an improvement over 2008. Braskem also outlined its strategic vision to become a leader in the Americas and one of the top five global petrochemical companies by 2020 through international expansion, technological autonomy, and feedstock diversification. Recent acquisitions of Quattor and Sunoco assets advance this strategy by creating a world-scale player with increased scale and geographic complementarity.
Detailed description of my experience in Information Technology, Distribution, and Environmental, Health and Safety as well as my expertise in creating high-performing, diverse teams, managing complex, global projects, and creating change throughout an organization.
Presentation by Bernd Blumenberg, president of BASF-YPC Co (BYC), at the Global Petrochemicals 7th Annual Meeting, organised by the World Refining Association (WRA)
- Russia was heavily impacted by the global economic recession, which led to a fall in domestic demand and consumption of petrochemical products in Russia.
- SIBUR, a major Russian petrochemical company, saw declines in production and sales during this period but was able to maintain relatively high operating rates in some segments through measures like expanding exports enabled by the devaluation of the Russian ruble.
- During the crisis, SIBUR implemented cost-cutting measures across its operations, including temporary shutdowns of some unprofitable production lines, reductions in capital expenditures, optimization of working capital, and reductions in administrative costs and headcount. Collaboration with government authorities was also important for supporting the industry during the downturn
This document summarizes a presentation given by Herb Soles of ISM (Independent School Management) to Turning Point School in Culver City, CA about endowments and fundraising. The presentation discusses what endowments are, compares endowment sizes of top colleges and independent schools, and provides strategies for schools to grow their endowments over time through creative investment, budget discipline, capital campaigns, and focus on planned giving. Benchmark data is also presented comparing average endowment sizes based on school type, size, region and growth. The goal is to help Turning Point School understand best practices to strengthen its long-term financial stability through endowment building.
Business & enterprise in year 8 9 options assemblyGeorg Coakley
The document summarizes the business and enterprise course options available to students in Year 9, including the skills developed, qualifications earned, opportunities for visits and speakers, and career paths the courses can lead to. Students are encouraged to choose business as they will receive help and support from teachers across flexible study methods. More information is available from the business teachers listed or by attending the Options Evening. A small competition is announced where students can win a £20 voucher by answering questions about the business courses and teachers.
Presentation by Theresa Kotanchek, vice president for sustainable technologie...ajagger
Delivering a Sustainable Future Through Innovation - presentation by Theresa Kotanchek, vice president for sustainable
technologies and innovation sourcing, Dow Chemical
Lena Perenius of Cefic discusses global chemicals regulationajagger
The document discusses challenges and opportunities in global chemical regulation. It outlines the goal of minimizing adverse impacts of chemicals by 2020 as agreed in 2002. It discusses trends towards regulatory convergence and cooperation between governments and industry. The Global Product Strategy is presented as industry's contribution to achieving the goals through initiatives like hazard information sharing and capacity building in developing countries by 2020.
Braskem announced strong fourth quarter 2009 results. EBITDA reached $614 million for the quarter, though this was lower than the previous quarter due to higher costs and lower sales volume. For the full year 2009, Braskem achieved $2.5 billion in EBITDA with a margin of 16.2%, an improvement over 2008. Braskem also outlined its strategic vision to become a leader in the Americas and one of the top five global petrochemical companies by 2020 through international expansion, technological autonomy, and feedstock diversification. Recent acquisitions of Quattor and Sunoco assets advance this strategy by creating a world-scale player with increased scale and geographic complementarity.
Detailed description of my experience in Information Technology, Distribution, and Environmental, Health and Safety as well as my expertise in creating high-performing, diverse teams, managing complex, global projects, and creating change throughout an organization.
Presentation by Bernd Blumenberg, president of BASF-YPC Co (BYC), at the Global Petrochemicals 7th Annual Meeting, organised by the World Refining Association (WRA)
- Russia was heavily impacted by the global economic recession, which led to a fall in domestic demand and consumption of petrochemical products in Russia.
- SIBUR, a major Russian petrochemical company, saw declines in production and sales during this period but was able to maintain relatively high operating rates in some segments through measures like expanding exports enabled by the devaluation of the Russian ruble.
- During the crisis, SIBUR implemented cost-cutting measures across its operations, including temporary shutdowns of some unprofitable production lines, reductions in capital expenditures, optimization of working capital, and reductions in administrative costs and headcount. Collaboration with government authorities was also important for supporting the industry during the downturn
This document summarizes a presentation given by Herb Soles of ISM (Independent School Management) to Turning Point School in Culver City, CA about endowments and fundraising. The presentation discusses what endowments are, compares endowment sizes of top colleges and independent schools, and provides strategies for schools to grow their endowments over time through creative investment, budget discipline, capital campaigns, and focus on planned giving. Benchmark data is also presented comparing average endowment sizes based on school type, size, region and growth. The goal is to help Turning Point School understand best practices to strengthen its long-term financial stability through endowment building.
Business & enterprise in year 8 9 options assemblyGeorg Coakley
The document summarizes the business and enterprise course options available to students in Year 9, including the skills developed, qualifications earned, opportunities for visits and speakers, and career paths the courses can lead to. Students are encouraged to choose business as they will receive help and support from teachers across flexible study methods. More information is available from the business teachers listed or by attending the Options Evening. A small competition is announced where students can win a £20 voucher by answering questions about the business courses and teachers.
Presentation by Theresa Kotanchek, vice president for sustainable technologie...ajagger
Delivering a Sustainable Future Through Innovation - presentation by Theresa Kotanchek, vice president for sustainable
technologies and innovation sourcing, Dow Chemical
ICIC 2016: Information Flow and the Commercialisation WindowDr. Haxel Consult
Information flow can be an important factor in understanding for how long the 'commercialisation window' can be open. Open for investment seeking, open for collaborative partner identification. In this talk Jane will call upon experience gained working with companies bringing innovative technologies into the market place to review handling information flows; including when to seek external information, the type of information needed, patent, IP, financial, market, company, technical, and how this can help with decision making.
This document provides information on the "Discovering the Route to Regulatory Compliance" conference taking place on September 23-24, 2015 in Barcelona, Spain. The conference will address topics related to regulatory compliance with REACH, including preparing for the 2018 registration deadline, managing substances of very high concern (SVHCs) and applications for authorization, substance and dossier evaluation, safety data sheets, and more. It lists keynote speakers from the European Chemicals Agency and industry organizations discussing these topics.
Harvesting Repositories: DPLA, Europeana, & Other Case Studieseohallor
Join this discussion on the benefits and process of harvesting to aggregators such as DPLA, Europeana and other aggregators. Through case studies we'll outline three stages of the process, including 1) mapping, migrating, and normalizing data in open source digital repositories, 2) making use of the Open Archives Initiative Protocol for Metadata Harvesting (OAI - PMH), and 3) reaping the benefits of increased exposure. Presenters welcome lively discussion and questions from participants of all technical backgrounds and skill levels.
USUGM 2014 - Jinling Sui (Flately Discovery): Building the Bioinformatic Pla...ChemAxon
Building a suitable bioinformatic platform for small molecule R&D with high throughput screening (HTS) is challenging for a small biotech startup with limited experiences and resource. At Flatley Discovery Lab, we started with desktop-based data process and library management applications in our initial chemical library build-up and HTS data processing. We have grown into an Oracle-based system, and implemented additional commercial packages on the platform. The system is designed and tailored to meet exactly the need of our biologists and chemists. With desktop-based component remains to be the front end for HTS raw data processing and data QC, advanced data analysis and visualization tools are introduced to support our SAR and lead development efforts. In only a few years since its inception, Flatley Discovery Lab has discovered several exciting CFTR modulators in the development pipeline toward a new and efficacious treatment for Cystic Fibrosis.
Safeguarding Chemical Regulations Compliance throughout the Supply ChainBaytouch Solutions
Malcolm Pollard, CEO of Baytouch Ltd, discusses the need for robust management system processes to safeguard supply chain chemical compliance. He notes the increasing complexity of global regulations and challenges of managing supplier information and changes. ProductTraq, Baytouch's product regulatory data storage and management solution, aims to automate otherwise manual processes for collecting, validating, and updating supplier documentation to facilitate compliance. When implemented properly, such systematic approaches can help companies increase response rates, improve change management, and lower risks to support best practices and sustainability.
Billion Dollar Bugs: When and How to Test a SpreadsheetTechWell
Gregory Pope from Lawrence Livermore National Laboratory presented on spreadsheet errors and testing. Some key points:
1) Several high-profile spreadsheet errors have cost companies and organizations billions of dollars due to things like missing minus signs, cut-and-paste errors, and incorrect formulas. Independent checks of spreadsheets are critical to avoid costly mistakes.
2) Studies show that even "finished" spreadsheets have error rates around 40-70%, which is 10 times higher than software error rates. However, spreadsheets are often not rigorously tested due to a lack of testing culture and skills.
3) Sarbanes-Oxley regulations require top management to certify the accuracy of financial information, increasing the need
REACH Registration - the next (big) hurdlekevenharlow
The document discusses the REACH registration process, which is the next major hurdle for companies dealing with chemical substances in the European Union. It provides an overview of pre-registration results and the current situation, emphasizing that actual registration is required by law to continue business operations. The presentation urges potential registrants to start preparing, budgeting resources and fees, and participating fully in their substance information exchange forums to avoid penalties that could disrupt supply chains or market access. Global chemical management regulations are tightening further over time.
Presentation - Phase 1 & BA/BE Process FlowInfo Kinetics
This document provides information about clinical research services offered by Info Kinetics Sdn Bhd /Clinical Research Centre. It summarizes their facilities including a 36-bed clinical pharmacology unit, bioanalytical laboratory, and data management capabilities. It also outlines their quality accreditations and experience conducting various types of clinical studies including phase 1 and bioavailability/bioequivalence studies. Timelines for pre-study activities, study conduct, and reporting are presented. Regulatory application processes are also described.
This document provides an overview and analysis of key developments related to the biopolymer polyethylene furanoate (PEF). It summarizes that PEF is a recyclable, bio-based alternative to polyethylene terephthalate (PET) that has superior barrier and mechanical properties. The document analyzes patent filing trends for PEF from 2005-2015, finding increasing filings from 2007-2012 with most applications originating from WO, US, and CN. Procter & Gamble and Canon are identified as top assignees. International patent classifications for PEF focus on macromolecular compounds and multilayer structures.
This document announces a conference on evolving guidelines for disclosing healthcare professional spending across Europe. The 6th Annual Global Transparency Reporting Congress will be held on April 7-8, 2016 in Frankfurt, Germany and will feature presentations from transparency reporting professionals from various pharmaceutical companies and industry associations. The conference will provide insights on implementing disclosure guidelines and managing compliance risks related to healthcare professional payments.
The document outlines the agenda for an upcoming Silicon Halton meetup. The agenda includes welcome and introductions, a progress report, upcoming community updates, a presentation on VC Pitching 101, a Q&A panel, and networking. It also provides details on the next meetup about open data and a community research and innovation jobs project being conducted by the Toronto Region Research Alliance to assess jobs in various sectors and match them to training programs.
The document discusses the history and objectives of the IP5, a group of the five largest patent offices (EPO, JPO, KIPO, SIPO, USPTO). It outlines the group's formation in 2007 and subsequent meetings where they agreed on 10 foundation projects and working groups to streamline patent processes. The goals are reducing backlogs, enabling examiners to access all relevant prior art, and facilitating international patent applications. The document also introduces the IP5 Landscape document which outlines short, medium and long term visions for cooperation between the five offices.
New Product Registration - Key Considerations when Registering New ProductsCovance
The regulation related to the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) was adopted by the EU in 2007 in response to worldwide initiatives to address the impact of chemicals on human health and the environment. REACH requires all manufacturers and importers of chemicals into European markets to assess and manage the risks associated with their substances and products, and register them with the European Chemicals Agency (ECHA). To manage this project, ECHA split existing substances into three categories, based on the amount of the substance that is used annually, with different registration deadlines for different tonnages of use.
Pharmalink Consulting provides regulatory affairs consulting services globally. It was founded in 1998 and has over 100 permanent staff and contractors. It helps clients with projects of all sizes, from small to large, domestic to multinational. Its clients include 18 of the top 20 healthcare companies. It has experience in Europe, North America, Latin America, Asia Pacific, the Middle East and Africa. It provides regulatory strategy, submissions, and interim staffing assistance. Case studies describe large product compliance projects, biosimilar submissions, and multinational clinical trials conducted for major pharmaceutical companies.
Pharmalink Consulting provides regulatory affairs consulting services with over 20 years of experience. They have a global network of over 100 permanent staff and freelance consultants. They assist clients with all stages of the regulatory lifecycle for pharmaceutical, biotech, medical device and other healthcare companies. Case studies describe large multi-year and multinational projects Pharmalink has undertaken for top pharmaceutical companies involving product compliance, clinical trials, and license applications across many countries and regions.
Pharmalink Consulting provides regulatory affairs consulting services globally. It was founded in 1998 and has over 100 permanent staff and contractors. It helps clients with projects of all sizes, from small to large, domestic to multinational. Its clients include 18 of the top 20 healthcare companies. It has experience in Europe, North America, Latin America, Asia Pacific, the Middle East and Africa. It provides regulatory strategy, submissions, and interim staffing assistance. Case studies describe large product compliance projects, biosimilar submissions, and multinational clinical trials conducted for major pharmaceutical companies.
This document discusses collaborative procurement in Scotland and provides guidance on the procurement process. It outlines the key drivers for collaboration including tight budgets and the ability to negotiate better deals. It also identifies essential tools for procurement including establishing requirements, governance structures, and maintaining open communication with suppliers. The document advises establishing expenditure needs, extending or creating contracts, and discussing needs with the procurement agency before finalizing agreements.
This document discusses ORCID (Open Researcher and Contributor Identifier), a global registry that assigns unique identifiers to researchers. It summarizes the development of the Australian ORCID Consortium, which aims to make Australia's research data more valuable by accurately linking researchers to their publications, data, and other work. The consortium launched in February 2016 with 40 institutional members and has since seen 15 members integrate ORCID into their systems, with many others in the planning or testing phases. The consortium took a national approach and collaborated extensively with stakeholders to achieve strong uptake. Benefits from ORCID implementation may take 3 years to fully realize.
FIPPA Implementation at OCAD. Report to the Board of Governors of the Ontario College of Art & Design. Jill Patrick, Director of Library Services, June 12, 2006.
Ontario Freedom of Information and Protection of Privacy Act, Access, Privacy, Responsibility, Independent Review, Reporting, Delegation, Implementation, FOI / Privacy Coordinator, Core Working Group, Extended Working Group, Terms of Reference, FOI Request, Concerns, Contacts.
SEC compliance and disclosure, Form 8-K (sample)Arthur Mboue
Form 8-K is a filing made by companies to announce significant corporate events to stakeholders. It covers events like bankruptcy, changes in executives or accountants, and delisting notices. The filing requirements have expanded over time from 6 categories in 1977 to 9 sections and 30 items currently. Proper compliance requires controls like checklists, documentation, legal review, and board oversight to ensure all triggering events are accurately reported.
Acolyte Episodes review (TV series) The Acolyte. Learn about the influence of the program on the Star Wars world, as well as new characters and story twists.
Here is Gabe Whitley's response to my defamation lawsuit for him calling me a rapist and perjurer in court documents.
You have to read it to believe it, but after you read it, you won't believe it. And I included eight examples of defamatory statements/
More Related Content
Similar to Quaker Chemical discusses Europe's new Reach regulations
ICIC 2016: Information Flow and the Commercialisation WindowDr. Haxel Consult
Information flow can be an important factor in understanding for how long the 'commercialisation window' can be open. Open for investment seeking, open for collaborative partner identification. In this talk Jane will call upon experience gained working with companies bringing innovative technologies into the market place to review handling information flows; including when to seek external information, the type of information needed, patent, IP, financial, market, company, technical, and how this can help with decision making.
This document provides information on the "Discovering the Route to Regulatory Compliance" conference taking place on September 23-24, 2015 in Barcelona, Spain. The conference will address topics related to regulatory compliance with REACH, including preparing for the 2018 registration deadline, managing substances of very high concern (SVHCs) and applications for authorization, substance and dossier evaluation, safety data sheets, and more. It lists keynote speakers from the European Chemicals Agency and industry organizations discussing these topics.
Harvesting Repositories: DPLA, Europeana, & Other Case Studieseohallor
Join this discussion on the benefits and process of harvesting to aggregators such as DPLA, Europeana and other aggregators. Through case studies we'll outline three stages of the process, including 1) mapping, migrating, and normalizing data in open source digital repositories, 2) making use of the Open Archives Initiative Protocol for Metadata Harvesting (OAI - PMH), and 3) reaping the benefits of increased exposure. Presenters welcome lively discussion and questions from participants of all technical backgrounds and skill levels.
USUGM 2014 - Jinling Sui (Flately Discovery): Building the Bioinformatic Pla...ChemAxon
Building a suitable bioinformatic platform for small molecule R&D with high throughput screening (HTS) is challenging for a small biotech startup with limited experiences and resource. At Flatley Discovery Lab, we started with desktop-based data process and library management applications in our initial chemical library build-up and HTS data processing. We have grown into an Oracle-based system, and implemented additional commercial packages on the platform. The system is designed and tailored to meet exactly the need of our biologists and chemists. With desktop-based component remains to be the front end for HTS raw data processing and data QC, advanced data analysis and visualization tools are introduced to support our SAR and lead development efforts. In only a few years since its inception, Flatley Discovery Lab has discovered several exciting CFTR modulators in the development pipeline toward a new and efficacious treatment for Cystic Fibrosis.
Safeguarding Chemical Regulations Compliance throughout the Supply ChainBaytouch Solutions
Malcolm Pollard, CEO of Baytouch Ltd, discusses the need for robust management system processes to safeguard supply chain chemical compliance. He notes the increasing complexity of global regulations and challenges of managing supplier information and changes. ProductTraq, Baytouch's product regulatory data storage and management solution, aims to automate otherwise manual processes for collecting, validating, and updating supplier documentation to facilitate compliance. When implemented properly, such systematic approaches can help companies increase response rates, improve change management, and lower risks to support best practices and sustainability.
Billion Dollar Bugs: When and How to Test a SpreadsheetTechWell
Gregory Pope from Lawrence Livermore National Laboratory presented on spreadsheet errors and testing. Some key points:
1) Several high-profile spreadsheet errors have cost companies and organizations billions of dollars due to things like missing minus signs, cut-and-paste errors, and incorrect formulas. Independent checks of spreadsheets are critical to avoid costly mistakes.
2) Studies show that even "finished" spreadsheets have error rates around 40-70%, which is 10 times higher than software error rates. However, spreadsheets are often not rigorously tested due to a lack of testing culture and skills.
3) Sarbanes-Oxley regulations require top management to certify the accuracy of financial information, increasing the need
REACH Registration - the next (big) hurdlekevenharlow
The document discusses the REACH registration process, which is the next major hurdle for companies dealing with chemical substances in the European Union. It provides an overview of pre-registration results and the current situation, emphasizing that actual registration is required by law to continue business operations. The presentation urges potential registrants to start preparing, budgeting resources and fees, and participating fully in their substance information exchange forums to avoid penalties that could disrupt supply chains or market access. Global chemical management regulations are tightening further over time.
Presentation - Phase 1 & BA/BE Process FlowInfo Kinetics
This document provides information about clinical research services offered by Info Kinetics Sdn Bhd /Clinical Research Centre. It summarizes their facilities including a 36-bed clinical pharmacology unit, bioanalytical laboratory, and data management capabilities. It also outlines their quality accreditations and experience conducting various types of clinical studies including phase 1 and bioavailability/bioequivalence studies. Timelines for pre-study activities, study conduct, and reporting are presented. Regulatory application processes are also described.
This document provides an overview and analysis of key developments related to the biopolymer polyethylene furanoate (PEF). It summarizes that PEF is a recyclable, bio-based alternative to polyethylene terephthalate (PET) that has superior barrier and mechanical properties. The document analyzes patent filing trends for PEF from 2005-2015, finding increasing filings from 2007-2012 with most applications originating from WO, US, and CN. Procter & Gamble and Canon are identified as top assignees. International patent classifications for PEF focus on macromolecular compounds and multilayer structures.
This document announces a conference on evolving guidelines for disclosing healthcare professional spending across Europe. The 6th Annual Global Transparency Reporting Congress will be held on April 7-8, 2016 in Frankfurt, Germany and will feature presentations from transparency reporting professionals from various pharmaceutical companies and industry associations. The conference will provide insights on implementing disclosure guidelines and managing compliance risks related to healthcare professional payments.
The document outlines the agenda for an upcoming Silicon Halton meetup. The agenda includes welcome and introductions, a progress report, upcoming community updates, a presentation on VC Pitching 101, a Q&A panel, and networking. It also provides details on the next meetup about open data and a community research and innovation jobs project being conducted by the Toronto Region Research Alliance to assess jobs in various sectors and match them to training programs.
The document discusses the history and objectives of the IP5, a group of the five largest patent offices (EPO, JPO, KIPO, SIPO, USPTO). It outlines the group's formation in 2007 and subsequent meetings where they agreed on 10 foundation projects and working groups to streamline patent processes. The goals are reducing backlogs, enabling examiners to access all relevant prior art, and facilitating international patent applications. The document also introduces the IP5 Landscape document which outlines short, medium and long term visions for cooperation between the five offices.
New Product Registration - Key Considerations when Registering New ProductsCovance
The regulation related to the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) was adopted by the EU in 2007 in response to worldwide initiatives to address the impact of chemicals on human health and the environment. REACH requires all manufacturers and importers of chemicals into European markets to assess and manage the risks associated with their substances and products, and register them with the European Chemicals Agency (ECHA). To manage this project, ECHA split existing substances into three categories, based on the amount of the substance that is used annually, with different registration deadlines for different tonnages of use.
Pharmalink Consulting provides regulatory affairs consulting services globally. It was founded in 1998 and has over 100 permanent staff and contractors. It helps clients with projects of all sizes, from small to large, domestic to multinational. Its clients include 18 of the top 20 healthcare companies. It has experience in Europe, North America, Latin America, Asia Pacific, the Middle East and Africa. It provides regulatory strategy, submissions, and interim staffing assistance. Case studies describe large product compliance projects, biosimilar submissions, and multinational clinical trials conducted for major pharmaceutical companies.
Pharmalink Consulting provides regulatory affairs consulting services with over 20 years of experience. They have a global network of over 100 permanent staff and freelance consultants. They assist clients with all stages of the regulatory lifecycle for pharmaceutical, biotech, medical device and other healthcare companies. Case studies describe large multi-year and multinational projects Pharmalink has undertaken for top pharmaceutical companies involving product compliance, clinical trials, and license applications across many countries and regions.
Pharmalink Consulting provides regulatory affairs consulting services globally. It was founded in 1998 and has over 100 permanent staff and contractors. It helps clients with projects of all sizes, from small to large, domestic to multinational. Its clients include 18 of the top 20 healthcare companies. It has experience in Europe, North America, Latin America, Asia Pacific, the Middle East and Africa. It provides regulatory strategy, submissions, and interim staffing assistance. Case studies describe large product compliance projects, biosimilar submissions, and multinational clinical trials conducted for major pharmaceutical companies.
This document discusses collaborative procurement in Scotland and provides guidance on the procurement process. It outlines the key drivers for collaboration including tight budgets and the ability to negotiate better deals. It also identifies essential tools for procurement including establishing requirements, governance structures, and maintaining open communication with suppliers. The document advises establishing expenditure needs, extending or creating contracts, and discussing needs with the procurement agency before finalizing agreements.
This document discusses ORCID (Open Researcher and Contributor Identifier), a global registry that assigns unique identifiers to researchers. It summarizes the development of the Australian ORCID Consortium, which aims to make Australia's research data more valuable by accurately linking researchers to their publications, data, and other work. The consortium launched in February 2016 with 40 institutional members and has since seen 15 members integrate ORCID into their systems, with many others in the planning or testing phases. The consortium took a national approach and collaborated extensively with stakeholders to achieve strong uptake. Benefits from ORCID implementation may take 3 years to fully realize.
FIPPA Implementation at OCAD. Report to the Board of Governors of the Ontario College of Art & Design. Jill Patrick, Director of Library Services, June 12, 2006.
Ontario Freedom of Information and Protection of Privacy Act, Access, Privacy, Responsibility, Independent Review, Reporting, Delegation, Implementation, FOI / Privacy Coordinator, Core Working Group, Extended Working Group, Terms of Reference, FOI Request, Concerns, Contacts.
SEC compliance and disclosure, Form 8-K (sample)Arthur Mboue
Form 8-K is a filing made by companies to announce significant corporate events to stakeholders. It covers events like bankruptcy, changes in executives or accountants, and delisting notices. The filing requirements have expanded over time from 6 categories in 1977 to 9 sections and 30 items currently. Proper compliance requires controls like checklists, documentation, legal review, and board oversight to ensure all triggering events are accurately reported.
Similar to Quaker Chemical discusses Europe's new Reach regulations (20)
Acolyte Episodes review (TV series) The Acolyte. Learn about the influence of the program on the Star Wars world, as well as new characters and story twists.
Here is Gabe Whitley's response to my defamation lawsuit for him calling me a rapist and perjurer in court documents.
You have to read it to believe it, but after you read it, you won't believe it. And I included eight examples of defamatory statements/
04062024_First India Newspaper Jaipur.pdfFIRST INDIA
Find Latest India News and Breaking News these days from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and Coronavirus News in India and the world over that you can't miss. For real time update Visit our social media handle. Read First India NewsPaper in your morning replace. Visit First India.
CLICK:- https://firstindia.co.in/
#First_India_NewsPaper
An astonishing, first-of-its-kind, report by the NYT assessing damage in Ukraine. Even if the war ends tomorrow, in many places there will be nothing to go back to.
Essential Tools for Modern PR Business .pptxPragencyuk
Discover the essential tools and strategies for modern PR business success. Learn how to craft compelling news releases, leverage press release sites and news wires, stay updated with PR news, and integrate effective PR practices to enhance your brand's visibility and credibility. Elevate your PR efforts with our comprehensive guide.
El Puerto de Algeciras continúa un año más como el más eficiente del continente europeo y vuelve a situarse en el “top ten” mundial, según el informe The Container Port Performance Index 2023 (CPPI), elaborado por el Banco Mundial y la consultora S&P Global.
El informe CPPI utiliza dos enfoques metodológicos diferentes para calcular la clasificación del índice: uno administrativo o técnico y otro estadístico, basado en análisis factorial (FA). Según los autores, esta dualidad pretende asegurar una clasificación que refleje con precisión el rendimiento real del puerto, a la vez que sea estadísticamente sólida. En esta edición del informe CPPI 2023, se han empleado los mismos enfoques metodológicos y se ha aplicado un método de agregación de clasificaciones para combinar los resultados de ambos enfoques y obtener una clasificación agregada.